financetom
Business
financetom
/
Business
/
BorgWarner's second-quarter profit beats on auto parts demand
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
BorgWarner's second-quarter profit beats on auto parts demand
Jul 31, 2024 8:17 AM

(Reuters) - BorgWarner ( BWA ) beat Wall Street expectations for second-quarter profit and raised its annual earnings forecast on Wednesday as the auto parts supplier benefited from sustained demand, sending its shares up about 9%.

Demand for combustion and hybrid vehicles has aided auto parts suppliers as car manufacturers delay their EV ambitions to focus on higher margin gas-powered models instead.

BorgWarner ( BWA ) will also restructure its ePropulsion unit, which makes electric motors, and said it expects the move to generate annual cost savings of about $100 million by 2026.

The company added that it plans to repurchase $300 million of its outstanding shares during the second half of the year.

CFRA analyst Garrett Nelson called BorgWarner's ( BWA ) results "one of the stronger ones among the U.S. auto suppliers" but said the research firm would maintain its "Hold" rating over concerns due to bloated inventory levels.

For the full year, BorgWarner ( BWA ) forecast adjusted net income per share to be between $3.95 and $4.15, up from its prior view of $3.80 to $4.15.

On an adjusted basis, the company earned $1.19 per share in the quarter ended June 30, compared with analysts' estimates of $1.01 per share, according to LSEG data.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Nvidia Stock Drops On Report Amazon Has 'Fully Transitioned' AI Chip Orders: The Details
Nvidia Stock Drops On Report Amazon Has 'Fully Transitioned' AI Chip Orders: The Details
May 21, 2024
NVIDIA Corp ( NVDA ) shares are falling in early trading Tuesday following a report suggesting Amazon.com Inc ( AMZN ) halted orders of the company’s “superchip” in order to wait for updated models. What To Know: According to a Financial Times report, Amazon’s cloud computing business has stopped ordering Nvidia’s most advanced superchip as the company plans to wait...
KKR Injects Cash And Expertise Into Healthcare Tech Company Infinx
KKR Injects Cash And Expertise Into Healthcare Tech Company Infinx
May 21, 2024
KKR & Co. Inc. ( KKR ) disclosed the acquisition of significant minority stake in Infinx, a provider of data-driven revenue cycle management solutions for the healthcare sector, with a particular focus on the U.S. market. The financial terms were not disclosed. With this, KKR expects to leverage its vast experience in the global healthcare and technology sectors to drive Infinx’s growth, boost its network, and...
PPG Industries to Invest $300 Million to Boost North American Manufacturing Capacity
PPG Industries to Invest $300 Million to Boost North American Manufacturing Capacity
May 21, 2024
09:54 AM EDT, 05/21/2024 (MT Newswires) -- PPG Industries ( PPG ) said Tuesday that it will invest $300 million over the next four years to boost its manufacturing capacity in North America in response to increased demand for automotive paints and coatings. As part of the investment, the company said it will build a 250,000-square-foot paint and coatings manufacturing...
Guardant Health Gets EU Certification for Blood-Based Test for Comprehensive Genomic Profiling of Solid Cancers
Guardant Health Gets EU Certification for Blood-Based Test for Comprehensive Genomic Profiling of Solid Cancers
May 21, 2024
09:53 AM EDT, 05/21/2024 (MT Newswires) -- Guardant Health ( GH ) said Tuesday that its Guardant360 CDx blood-based test for comprehensive genomic profiling of solid cancers has received certification under the European Union's In Vitro Diagnostic Regulation. The test is certified as a companion diagnostic to identify non-small cell lung cancer patients who may benefit from treatment with osimertinib,...
Copyright 2023-2026 - www.financetom.com All Rights Reserved